iShares Genomics Immunology and Healthcare ETF (IDNA) Holdings $21.06 +0.39 (+1.89%) As of 05/2/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Top 50 IDNA HoldingsRankCompanyCurrent PriceWeightShares Held1BeiGene, Ltd.N/A5.73%333,0002GSK plcN/A5.32%309,8413Roche Holding AGN/A5.29%18,1144SanofiN/A5.25%54,4985EXELExelixis$39.60+1.8%5.18%148,1506AstraZeneca PLCN/A5.01%39,0867Takeda Pharmaceutical Company LimitedN/A4.97%181,6008SWTXSpringWorks Therapeutics$46.23+0.0%4.88%116,0969Genmab A/SN/A4.53%24,19110RVMDRevolution Medicines$40.72+0.2%4.17%110,429 Get the Latest News and Ratings for IDNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. 11BNTXBioNTech$104.94+2.5%4.12%43,56312MRKMerck & Co., Inc.$83.14-0.1%3.90%51,47713INCYIncyte$62.53+0.8%3.79%69,89914REGNRegeneron Pharmaceuticals$605.61+2.6%3.79%6,82215ACLXArcellx$65.55+0.0%3.69%62,78016TWSTTwist Bioscience$39.24+4.1%3.61%99,31017MRNAModerna$27.61+2.1%2.99%119,46918BCRXBioCryst Pharmaceuticals$8.93+2.5%2.52%332,91119JANXJanux Therapeutics$32.88+2.6%2.39%81,59920NVAXNovavax$6.411.65%269,67021IOVAIovance Biotherapeutics$3.50+5.1%1.43%435,30222GERNGeron$1.38-3.5%1.27%995,32523SK bioscience Co.,Ltd.N/A1.14%45,31924XNCRXencor$11.26+3.7%1.12%116,19225ABCLAbCellera Biologics$2.41-3.2%0.92%391,87226VIRVir Biotechnology$6.16+1.3%0.86%154,18927Valneva SEN/A0.73%240,33228IMNMImmunome$8.85-0.1%0.70%89,25229IBRXImmunityBio$2.54+2.0%0.68%282,05730KURAKura Oncology$6.47-0.3%0.68%115,38331RCUSArcus Biosciences$9.12+5.8%0.64%84,59732VERVVerve Therapeutics$5.19-5.6%0.58%110,94233MREOMereo BioPharma Group$2.67+2.7%0.57%242,03934CELCCelcuity$10.90+0.9%0.54%53,85035RIGLRigel Pharmaceuticals$19.36+3.4%0.54%30,36236ARCTArcturus Therapeutics$12.83+2.6%0.50%43,22037DNAGinkgo Bioworks$7.04+1.1%0.47%63,85838PACBPacific Biosciences of California$1.13+1.8%0.44%424,92739Ono Pharmaceutical Co., Ltd.N/A0.43%40,90040ALLOAllogene Therapeutics$1.70+0.6%0.36%250,460Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why41ORICORIC Pharmaceuticals$5.67+1.8%0.34%74,09442CRSPCRISPR Therapeutics$38.25+1.4%0.33%9,52343OABIOmniAb$1.75-1.1%0.28%171,21644CRGXCARGO Therapeutics$4.32-1.1%0.24%56,31845SGMOSangamo Therapeutics$0.73-1.7%0.24%351,15946FDMT4D Molecular Therapeutics$3.76+9.3%0.21%68,59847LGNDLigand Pharmaceuticals$109.39+0.2%0.21%2,16848BEAMBeam Therapeutics$20.24+2.1%0.15%8,55749BLK CSH FND TREASURY SL AGENCYN/A0.13%140,00050USDProShares Ultra Semiconductors$42.10+5.7%0.12%137,120 Geographic ExposureUnited States59.4%Cayman Islands6.1%France6.0%Switzerland5.6%Japan5.4%United Kingdom5.0%Denmark4.6%Canada0.9%Currency ExposureUSD60.8%GBP10.6%HKD6.1%EUR6.1%JPY5.5%CHF5.3%DKK4.6%KRW1.1%Sector ExposureHealth Care99.1%Chemicals0.4%Industry ExposureBiotechnology92.3%Pharmaceuticals5.5%Diversified Consumer Services0.5%Health Care Equipment & Supplies0.4%Chemicals0.4%Life Sciences Tools & Services0.3%SubIndustry ExposureBiotechnology90.5%Pharmaceuticals5.5%Life Sciences Tools & Services0.7%Specialty Chemicals0.4%Coupon Exposure0-299.8%4-60.2% Related Companies and Tools Related Companies Global X Video Games & Esports ETF Top Holdings Global X Millennial Consumer ETF Top Holdings SPDR S&P Kensho Clean Power ETF Top Holdings Amplify Alternative Harvest ETF Top Holdings Global X Social Media Index ETF Top Holdings Valkyrie Bitcoin Miners ETF Top Holdings WisdomTree Cybersecurity Fund Top Holdings American Conservative Values ETF Top Holdings Avantis Responsible Emerging Markets Equity ETF Top Holdings VanEck Low Carbon Energy ETF Top Holdings This page (NYSEARCA:IDNA) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.